跳至主要内容
临床试验/CTRI/2025/12/098688
CTRI/2025/12/098688尚未招募不适用

A Randomized, Comparative, Single-Dose, Crossover, 3 Sequence Study to Assess the Bioavailability of Formulated Vitamin C (DELT) in Comparison with Liposomal and Reference Vitamin C Supplementations in Healthy Volunteers.

Encapscifi Lifesciences Pvt. Ltd.1 个研究点 分布在 1 个国家目标入组 12 人开始时间: 2025年12月18日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
12
试验地点
1
主要终点
To estimate the concentrations of vitamin C in DELT vitamin C in comparison with conventional vitamin C and plain vitamin C supplementation.

研究概览

简要总结

This is a comparative single-dose, crossover, 3-sequence study to compare the bioavailability of DELT vitamin C in comparison with conventional vitamin C and plain vitamin C. A group of 12 Healthy volunteers willing to give a written informed consent will be screened on Visit 1 to confirm eligibility. Subjects fulfilling the eligibility criteria will be assigned into 1 of 3-treatment sequence on Visit 2 followed by cross-over to the other treatment sequences on subsequent visits. There will be washout period between each dosing day.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
Participant and Investigator Blinded

入排标准

年龄范围
20.00 Year(s) 至 55.00 Year(s)(—)
性别
All

入选标准

  • Subject who agree not to consume any vitamin C based foods throughout the study.
  • Females of child bearing age, agree to use approved birth control methods during the study, and have negative urine pregnancy test (UPT) at screening.
  • Subject understands the study procedures, is ready to comply and provide signed informed consent form (ICF) to participate in the study.

排除标准

  • 1.Subjects who have consumed either Vitamin C containing food/supplement 7 days prior to screening.
  • 2.Pregnant or lactating women.
  • 3.Subjects with known hypersensitivity to the investigational products.
  • 4.Subjects who have participated in any clinical trial in the past 1 month.
  • 5.Any subjects found to have entered in to the study in violation of this protocol or if the subject is uncooperative during the study.
  • 6.Any other condition that in the opinion of the investigator that does not justify the subject’s participation in the trial.

结局指标

主要结局

To estimate the concentrations of vitamin C in DELT vitamin C in comparison with conventional vitamin C and plain vitamin C supplementation.

时间窗: Period 1, Period 2, Period 3

次要结局

  • Pharmacokinetics parameters of DELT vitamin C in comparison with conventional vitamin C and plain vitamin C.(Baseline, Day 9, Day 17)
  • Safety and tolerability of DELT vitamin C in comparison with conventional vitamin C and plain vitamin C.(Baseline, Day 9, Day 17)

研究者

发起方
Encapscifi Lifesciences Pvt. Ltd.
申办方类型
Other [Manufacturer of natural plant based Food ingredients and Nutraceutical ingredients]
责任方
Principal Investigator
主要研究者

Dr Jayashree S Seeri

BGS Global Institute of Medical Sciences

研究点 (1)

Loading locations...

相似试验